Psoriasis market to grow at 1.7% CAGR from 2025-2034 due to biologic innovations. Transition to high-efficacy treatments noted.

The market for psoriasis is steadily growing due to an increase in the number of people suffering from the disease, better detection rates, and increased patient availability of advanced treatments. There has been a notable transition from traditional systemic treatments to more effective biologics and targeted oral medications. This shift has led to a significant increase in revenue, with the market now valued at approximately [provide exact number if available].